Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury
Immunity, Inflammation and Disease · 2026-04 · 14 (4)
DOI: 10.1002/iid3.70364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 02.04.2026. Verfasst von Xuesong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Hauptthemen laut MEDLINE: Ginkgolides, Hyperoxia, Lactones, Lung Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bronchopulmonary dysplasia (BPD) is a chronic lung disease characterized by inflammation, often caused by prolonged hyperoxia exposure in preterm infants. Platelet‐activating factor (PAF) is a potent inflammatory mediator, but its role in BPD is unclear. This study explores the therapeutic potential of the PAF receptor antagonist Ginkgolide B (GB) in hyperoxia‐induced lung injury.
Methods
We observed the activation status of platelets and neutrophils in BALF(bronchoalveolar lavage fluid) of patients with BPD. The supernatant of BALF from patients was sent for protein chip detection and validated by ELISA. We also measured the levels of PAF in peripheral blood and BALF. In vitro experiments, we stimulated neutrophils with PAF to detect the expression of inflammatory cytokine genes. Finally, we established a neonatal rat model of hyperoxia‐induced lung injury mimicking BPD and intervened with GB.
Results
We observed early activation of platelets and neutrophils in the peripheral blood of BPD patients, with elevated plasma levels of PAF and myeloperoxidase‐DNA (MPO‐DNA). In BALF, neutrophils showed increased CD66b and MPO expression. In vitro, PAF stimulation decreased CD62L expression on neutrophils and upregulated IL‐6 mRNA. Elevated levels of PAF, IL‐6, IL‐8, and GM‐CSF were found in BPD infants' BALF supernatant. Using animal models of BPD, we found that GB significantly reduced lung damage in hyperoxia‐exposed rats. GB decreased neutrophil‐derived IL‐6 and downregulated key proteins in the IL‐6 signaling pathway (pJak2 and pStat3).
Conclusion
Our study demonstrates that PAF activates neutrophils and promotes their lung residence. GB effectively inhibits neutrophil‐derived IL‐6 and alleviates hyperoxia‐induced lung damage. Targeting the PAF pathway with GB may be a promising strategy for BPD and other hyperoxia‐related lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Pathology, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: ShuShu Wang
Zitieren
APA
Wang, X., Chen, M., Lv, Y., Qi, Y., Huang, D., & Wang, S. (2026). Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70364
Vancouver
Wang X, Chen M, Lv Y, Qi Y, Huang D, Wang S. Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70364
BibTeX
@article{Wang2026,
author = {Wang, Xuesong and Chen, Mingwu and Lv, Yong and Qi, Yue and Huang, Dake and Wang, ShuShu},
title = {Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/iid3.70364}
}
EUVIMED